Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 31, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that Steven L. Zelenkofske, D.O., F.A.C.C., has been appointed Patient Safety Officer and...
-
Oct 25, 2006Positive results also reported for TAXUS Liberte stent direct stenting
Boston Scientific Corporation (NYSE: BSX) today announced 12-month follow-up data from TAXUS ATLAS, the pivotal clinical trial...
-
Oct 25, 2006
Boston Scientific Corporation (NYSE: BSX) today announced positive results from its global TAXUS OLYMPIA registry, supporting the...
-
Oct 23, 2006Results also show statistically significant late stent thrombosis rate for Cypher® stent vs. bare-metal stent
Boston Scientific Corporation (NYSE: BSX) today announced that an independent meta-analysis of more than 3,500 patients from five...
-
Oct 23, 2006Two-year results continue to evaluate long-term safety and efficacy
Boston Scientific (NYSE: BSX) today announced two-year data from its BEACH carotid artery stenting (CAS) clinical trial. The study...
-
Oct 23, 2006Multi-center registry to enroll 10,000 patients over two years
Boston Scientific Corporation (NYSE: BSX) today announced that it intends to provide lead financial support for an extension of the...
-
Oct 22, 2006
Boston Scientific Corporation (NYSE: BSX) today announced one-year results from its TC-WYRE (TAXUS® Express2™ Stent vs. Cypher Stent: What's...
-
Oct 18, 2006
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2006. Net sales for the third...
-
Oct 18, 2006Results to include new data on next-generation TAXUS® Liberte™ Stent System
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 16, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the initiation of a new clinical trial designed to identify and investigate clinically...